Posted by Michael Wonder on 14 Dec 2015
Canada's ERC recommends panitumumab (Vectibix) for use by patients with metastatic RAS colorectal cancer
3 December 2015 - The ERC has recommended the use of panitumumab in combination with FOLFOX for the first-line treatment of patients with wild-type RAS metastatic colorectal cancer.
For more details, go to: https://www.cadth.ca/sites/default/files/pcodr/pcodr_panitumumab_vectibix_mcrc_fn_rec.pdf
